HUP0000664A3 - Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions - Google Patents
Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositionsInfo
- Publication number
- HUP0000664A3 HUP0000664A3 HU0000664A HUP0000664A HUP0000664A3 HU P0000664 A3 HUP0000664 A3 HU P0000664A3 HU 0000664 A HU0000664 A HU 0000664A HU P0000664 A HUP0000664 A HU P0000664A HU P0000664 A3 HUP0000664 A3 HU P0000664A3
- Authority
- HU
- Hungary
- Prior art keywords
- azinyloxy
- diaryl
- phenoxy
- preparation
- carboxylic acid
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cardiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19636046A DE19636046A1 (de) | 1996-09-05 | 1996-09-05 | Neue Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶A¶/ET¶B¶-Rezeptorantagonisten |
| PCT/EP1997/004688 WO1998009953A2 (de) | 1996-09-05 | 1997-09-02 | Azinyloxy- und phenoxy-diaryl-carbonsäure derivate, deren herstellung und deren verwendung als gemischte eta/etb endothelin-rezeptorantagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0000664A2 HUP0000664A2 (hu) | 2001-04-28 |
| HUP0000664A3 true HUP0000664A3 (en) | 2001-07-30 |
Family
ID=7804712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0000664A HUP0000664A3 (en) | 1996-09-05 | 1997-09-02 | Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6670367B1 (hu) |
| EP (1) | EP0929529A2 (hu) |
| JP (1) | JP2000517329A (hu) |
| KR (1) | KR20000068446A (hu) |
| CN (1) | CN1236362A (hu) |
| AR (1) | AR009543A1 (hu) |
| AU (1) | AU736414B2 (hu) |
| BG (1) | BG103258A (hu) |
| BR (1) | BR9711693A (hu) |
| CA (1) | CA2265504A1 (hu) |
| CO (1) | CO4900070A1 (hu) |
| DE (1) | DE19636046A1 (hu) |
| HU (1) | HUP0000664A3 (hu) |
| ID (1) | ID19417A (hu) |
| IL (1) | IL128743A0 (hu) |
| NO (1) | NO312674B1 (hu) |
| NZ (1) | NZ334548A (hu) |
| PL (1) | PL331998A1 (hu) |
| SK (1) | SK25999A3 (hu) |
| TR (1) | TR199900486T2 (hu) |
| WO (1) | WO1998009953A2 (hu) |
| ZA (1) | ZA977946B (hu) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6030975A (en) * | 1997-03-14 | 2000-02-29 | Basf Aktiengesellschaft | Carboxylic acid derivatives, their preparation and use in treating cancer |
| JP2001514254A (ja) * | 1997-09-04 | 2001-09-11 | ビーエーエスエフ アクチェンゲゼルシャフト | 新規カルボン酸誘導体、その製造及び混合ｅｔａ／ｅｔｂエンドセリン受容体拮抗薬としてのその使用 |
| BR9812531A (pt) * | 1997-09-26 | 2000-07-25 | Knoll Ag | Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica |
| DE19743143A1 (de) * | 1997-09-30 | 1999-04-01 | Knoll Ag | Pharmazeutische Kombinationspräparate |
| HU0900792D0 (en) * | 1997-10-17 | 2010-03-01 | Ark Therapeutics Ltd | Use of renin-angiotensin inhibitors |
| DE19809144A1 (de) * | 1998-03-04 | 1999-09-09 | Basf Ag | Neue unsymmetrisch substituierte Carbonsäurederivate, ihre Herstellung und Verwendung als gemischte ET¶LAMBDA¶/ET¶B¶-Rezeptorantagonisten |
| DE19836044A1 (de) * | 1998-08-10 | 2000-02-17 | Basf Ag | Neue Carbonsäurederivate, die Ketoseitenketten tragen, ihre Herstellung und Verwendung als Endothelin-Rezeptorantagonisten |
| US7566452B1 (en) | 1999-05-04 | 2009-07-28 | New York University | Cancer treatment with endothelin receptor antagonists |
| DE19933164A1 (de) * | 1999-07-20 | 2001-01-25 | Basf Ag | Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| DE19951671A1 (de) * | 1999-10-27 | 2001-05-03 | Basf Ag | 2-(4,6-Dimethyl-pyrimidin-2-yloxy)-3-(2-(3,4-dimethoxyphenyl)ethoxy)-3,3-diphenylpropionssäure-Natriumsalz und seine Verwendung als Endothelinantagonist |
| DE10064797A1 (de) * | 2000-12-22 | 2002-06-27 | Knoll Ag | Orale und parenterale pharmazeutische Formulierung, umfassend eine niedermolekulare Thrombininhibitor-Pro-Pharmakon |
| JP4155561B2 (ja) * | 2000-12-26 | 2008-09-24 | 国立大学法人佐賀大学 | アレルギー性疾患検査方法 |
| DK1243262T3 (da) | 2001-03-20 | 2006-10-02 | Sanol Arznei Schwarz Gmbh | Hidtil ukendt anvendelse af en peptidklasse af forbindelser til behandling af ikke-neuropatiske, inflammatoriske smerter |
| EP1243263B1 (en) | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| NZ550482A (en) | 2004-04-16 | 2010-08-27 | Sanol Arznei Schwarz Gmbh | Use of peptidic compounds for the prophylaxis and treatment of chronic headache |
| EP1604656A1 (en) | 2004-06-09 | 2005-12-14 | Schwarz Pharma Ag | Novel use of peptide compounds for treating amyotrophic lateral sclerosis (ALS) |
| CA2573125A1 (en) | 2004-08-27 | 2006-03-02 | Schwarz Pharma Ag | Novel use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain |
| MX2008011844A (es) * | 2006-03-13 | 2008-10-02 | Encysive Pharmaceuticals Inc | Formulaciones de sitaxsentano de sodio. |
| MX2008011842A (es) * | 2006-03-13 | 2008-10-02 | Encysive Pharmaceuticals Inc | Procedimientos y composiciones para el tratamiento de insuficiencia cardiaca diastolica. |
| ES2450070T5 (es) | 2006-06-15 | 2018-05-08 | Ucb Pharma Gmbh | Composición farmacéutica que comprende lacosamida y levetiracetam con efecto anticonvulsionante sinérgico |
| US20080026061A1 (en) * | 2006-06-22 | 2008-01-31 | Reichwein John F | Crystalline N-(4-chloro-3-methyl-5-isoxazolyl)-2-[2-methyl-4.5-(methylenedioxy)phenylacetyl]-thiophene-3-sulfonamide |
| CN103709106A (zh) * | 2013-12-06 | 2014-04-09 | 石家庄博策生物科技有限公司 | 一种立体选择性制备安立生坦的方法 |
| CN103739557B (zh) * | 2013-12-30 | 2015-10-21 | 黄河三角洲京博化工研究院有限公司 | 一种4,6-二甲基-2-甲磺酰基嘧啶的合成方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4313412A1 (de) * | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| DE4313413A1 (de) * | 1993-04-23 | 1994-10-27 | Basf Ag | 3-(Het)aryloxy(thio)-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung |
| DE4335950A1 (de) | 1993-10-21 | 1995-04-27 | Basf Ag | Derivate von 3-Hydroxycarbonsäuren, deren Herstellung und Verwendung |
| DE4411225A1 (de) | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19536891A1 (de) | 1995-10-04 | 1997-04-10 | Basf Ag | Neue Aminosäurederivate, ihre Herstellung und Verwendung |
-
1996
- 1996-09-05 DE DE19636046A patent/DE19636046A1/de not_active Withdrawn
-
1997
- 1997-03-02 US US09/254,137 patent/US6670367B1/en not_active Expired - Fee Related
- 1997-09-02 JP JP10512203A patent/JP2000517329A/ja active Pending
- 1997-09-02 AU AU45524/97A patent/AU736414B2/en not_active Ceased
- 1997-09-02 NZ NZ334548A patent/NZ334548A/xx unknown
- 1997-09-02 CN CN97199458A patent/CN1236362A/zh active Pending
- 1997-09-02 IL IL12874397A patent/IL128743A0/xx unknown
- 1997-09-02 CA CA002265504A patent/CA2265504A1/en not_active Abandoned
- 1997-09-02 PL PL97331998A patent/PL331998A1/xx unknown
- 1997-09-02 HU HU0000664A patent/HUP0000664A3/hu unknown
- 1997-09-02 KR KR1019997001815A patent/KR20000068446A/ko not_active Application Discontinuation
- 1997-09-02 SK SK259-99A patent/SK25999A3/sk unknown
- 1997-09-02 WO PCT/EP1997/004688 patent/WO1998009953A2/de not_active Application Discontinuation
- 1997-09-02 BR BR9711693A patent/BR9711693A/pt not_active IP Right Cessation
- 1997-09-02 TR TR1999/00486T patent/TR199900486T2/xx unknown
- 1997-09-02 EP EP97943819A patent/EP0929529A2/de not_active Withdrawn
- 1997-09-04 ZA ZA977946A patent/ZA977946B/xx unknown
- 1997-09-04 CO CO97051479A patent/CO4900070A1/es unknown
- 1997-09-05 AR ARP970104059A patent/AR009543A1/es not_active Application Discontinuation
- 1997-09-05 ID IDP973110A patent/ID19417A/id unknown
-
1999
- 1999-03-04 NO NO19991079A patent/NO312674B1/no not_active IP Right Cessation
- 1999-03-16 BG BG103258A patent/BG103258A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR199900486T2 (xx) | 1999-06-21 |
| NZ334548A (en) | 2000-09-29 |
| JP2000517329A (ja) | 2000-12-26 |
| ZA977946B (en) | 1999-03-04 |
| NO312674B1 (no) | 2002-06-17 |
| EP0929529A2 (de) | 1999-07-21 |
| AU736414B2 (en) | 2001-07-26 |
| BG103258A (en) | 2000-12-29 |
| IL128743A0 (en) | 2000-01-31 |
| CA2265504A1 (en) | 1998-03-12 |
| CO4900070A1 (es) | 2000-03-27 |
| NO991079D0 (no) | 1999-03-04 |
| ID19417A (id) | 1998-07-09 |
| DE19636046A1 (de) | 1998-03-12 |
| PL331998A1 (en) | 1999-08-16 |
| WO1998009953A2 (de) | 1998-03-12 |
| WO1998009953A3 (de) | 1998-10-29 |
| BR9711693A (pt) | 1999-08-24 |
| AR009543A1 (es) | 2000-04-26 |
| SK25999A3 (en) | 1999-09-10 |
| KR20000068446A (ko) | 2000-11-25 |
| CN1236362A (zh) | 1999-11-24 |
| US6670367B1 (en) | 2003-12-30 |
| NO991079L (no) | 1999-05-04 |
| HUP0000664A2 (hu) | 2001-04-28 |
| AU4552497A (en) | 1998-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0000664A3 (en) | Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions | |
| HUP9801044A3 (en) | Sulfonylamino-carboxylic acid derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
| HUP9801045A3 (en) | Sulfonyl-amino-carboxylic acid derivatives, use thereof, pharmaceutical compositions containing them and process for their preparation | |
| IL117265A (en) | Benzazepine- benzoxazepine- and benzothiazepine-N-acetic acid derivatives their preparation and pharmaceutical compositions containing them | |
| IL120141A (en) | Substituted quinazoline derivatives process for their preparation and pharmaceutical compositions containing them | |
| HUP0001607A3 (en) | Thienopyrimidine derivatives, pharmaceutical compositions containing them, process for their preparation and use of the compounds | |
| HUP9700358A3 (en) | New oxazolidinon derivatives, process for their preparation and pharmaceutical compositions containing them | |
| IL145789A0 (en) | Derivatives of propionic acid, their preparation and pharmaceutical compositions containing them | |
| IL117193A0 (en) | Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them | |
| IL117598A (en) | Quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them | |
| HUP0001555A3 (en) | Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation | |
| HUP0102307A3 (en) | Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates | |
| HUP0002517A3 (en) | Derivatives of acyl-piperazinil-pyrimidins, preparation thereof, pharmaceutical compositions containing them and their use as medicaments | |
| HUP0002404A3 (en) | Amino acid derivatives, pharmaceutical compositions comprising thereof, process for preparation them and their use | |
| HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
| IL115072A0 (en) | Substituted 4-phenyl-6-amino-nicotinic acid derivatives their preparation pharmaceutical compositions containing them and their use | |
| HUP0002171A3 (en) | Aminophosphonic acid derivatives, method for their preparation and pharmaceutical compositions thereof | |
| HUP0002300A3 (en) | Quinoline-4-carboxamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
| HUP0001385A3 (en) | Pro-drugs and derivatives of camptothecin, process for their preparation, use thereof and pharmaceutical compositions containing them | |
| HUP0003053A3 (en) | Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them | |
| IL112936A0 (en) | Quinolone - and - naphthyridone - carboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| IL104356A0 (en) | Benzofuranyl-and thiophenylmethylthio-alkanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| CZ92295A3 (en) | Boronpeptide derivatives, process of their preparation and pharmaceutical composition containing thereof | |
| CZ346595A3 (en) | Substituted derivatives of 4-phenylthiazoles, process of their preparation and pharmaceutical compositions containing thereof | |
| HUP0001773A3 (en) | Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them |